510(k) Report

510(k) · Cleared

Cleared

Aaxter A3 Posterior Spinal System

K101374510(k) TraditionalCleared Mar 16, 2011303-day reviewClass II21 CFR 888.3070

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Aaxter Co., Ltd. · MNH Orthosis, Spondylolisthesis Spinal Fixation

Cleared on Mar 16, 2011 as substantially equivalent to K031595 (U&I Corp., America, 2003) after a 303-day review. Its family tree reaches back 3 generations to 1988.

Decided
Mar 16, 2011
Review
303 days
Class
Class II
Product code
MNH
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K884263 (1988). 9 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2000: 1 other ancestor1996: 1 other ancestor1997: 1 other ancestor1995: 2 other ancestors1990: 1 other ancestorK884263 · Rogozinski Spinal System · Richards Medical Co., Inc. · 1988K983904 · Rogozinski Spinal Rod System · United States Surgical, A Division of Tyco Healthc · 1998K031595 · U & I America Spinal Hook System · U&I Corp., America · 2003 · recalled198519901995200020052010
  1. Root · 3 generations backK884263 Rogozinski Spinal SystemRichards Medical Co., Inc. · 1988
  2. 2 generations backK983904 Rogozinski Spinal Rod SystemUnited States Surgical, A Division of Tyco Healthc · 1998
  3. 1 generation backK031595 U & I America Spinal Hook SystemU&I Corp., America · 2003 · Recalled
  4. This deviceK101374 Aaxter A3 Posterior Spinal SystemAaxter Co., Ltd. · 2011
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K884263Rogozinski Spinal SystemRichards Medical Co., Inc.1988—
−2K983904Rogozinski Spinal Rod SystemUnited States Surgical, A Division of Tyco Healthc1998—
−1K031595U & I America Spinal Hook SystemU&I Corp., America20033
0 (this device)K101374Aaxter A3 Posterior Spinal SystemAaxter Co., Ltd.2011—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199010
199520
199610
199710
200010
FIG. 1 — Lineage of K101374, 1988–2011Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MNH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K031595U & I America Spinal Hook System
Summary page 2
…ivalent in function materials, design, operational principles, composition, labeling, and intended use to: TMM U&J Ame'ica, Spinal Hook SystemT M , KWP-(K03 1595) Device Description: The Aaxter A3 Posterior Spinal System is a posterior spinal system which is a top loading multiple compo…
U&I Corp., America20033

Also cleared against K031595: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 4 companies; a new generation was cleared every 7.7 years on median.
  • 1 of the 9 ancestors has a recall of any class.
  • 2 other devices also cite its predicate K031595.

How does its category compare?

All MNH devices

MNH Orthosis, Spondylolisthesis Spinal Fixation: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · MNH

8in 2016

2007: 52008: 132009: 132010: 102011: 172012: 72013: 102014: 122015: 102016: 8
2007high 17 (2011) · low 0 (2017)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MNH

93in 2016

2007: 123 days median2008: 65 days median2009: 151 days median2010: 106 days median2011: 171 days median2012: 93 days median2013: 124 days median2014: 140 days median2015: 99 days median2016: 93 days median
2007high 171 (2011) · low 65 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MNH

1in 2016

2009: 72012: 12013: 12016: 1
2007high 7 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MNH

89in 2025

2007: 182008: 302009: 452010: 592011: 1072012: 4332013: 4642014: 2862015: 1522016: 2162017: 1742018: 1292019: 4032020: 4322021: 5312022: 2652023: 1212024: 3022025: 89
2007high 531 (2021) · low 18 (2007)2025

MAUDE reports naming product code MNH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20075123018
20081365030
200913151745
201010106059
2011171710107
20127931433
2013101241464
2014121400286
201510990152
20168931216
20170—0174
20180—0129
20190—0403
20200—0432
20210—0531
20220—0265
20230—0121
20240—0302
20250—089
20260—0—

What is it indicated for?

The Aaxter A3 Posterior Spinal System is intended for posterior pedicle and non-pedicle fixation in the non-cervical spine as an adjunct to fusion in skeletally mature patients for the following indication; spondylolisthesis (Grade 3 and 4), of the L5-S1 vertebra in skeletally-mature patients receiving fusion by autogenous bone graft having implants attainment to the lumbar and sacral spine with removal of implants after the attainment of a solid fusion.…

Read the full statement (136 words)

The Aaxter A3 Posterior Spinal System is intended for posterior pedicle and non-pedicle fixation in the non-cervical spine as an adjunct to fusion in skeletally mature patients for the following indication; spondylolisthesis (Grade 3 and 4), of the L5-S1 vertebra in skeletally-mature patients receiving fusion by autogenous bone graft having implants attainment to the lumbar and sacral spine with removal of implants after the attainment of a solid fusion.

In addition, the Aaxter A3 Posterior Spinal System is intended to provide immobilization and stabilization of spinal segments in skeletally-mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of the thoracic, lumbar and sacral spine:

"Degenerative spondylolisthesis with objective evidence of neurological impairment

* Fracture of the vertebral body

* Dislocation

- Scoliosis

* Kyphosis

"Spinal tumnor

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K101374: Aaxter A3 Posterior Spinal System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K101374

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026